Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/31/2002WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs
10/31/2002WO2002085309A2 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
10/31/2002WO2002085308A2 Antisense and anti-inflammatory based compositions to treat respiratory disorders
10/31/2002WO2002085306A2 Use of follistatin to increase muscle mass
10/31/2002WO2002085305A2 Compositions and methods for inducing cancer cell death
10/31/2002WO2002085302A2 Methods of treating intestinal inflammation
10/31/2002WO2002085298A2 Method for detecting breast cancer cells
10/31/2002WO2002085295A2 Methods and compositions for the modulation of biofilm formation
10/31/2002WO2002085293A2 Production of alpha-lipoic acid
10/31/2002WO2002085287A2 Minimal adenoviral vectors for immunization
10/31/2002WO2002085285A2 Methods and reagents for regulating bone and cartilage formation
10/31/2002WO2002085105A2 Tomato plants that exhibit resistance to $i(botrytis cinerea)
10/31/2002WO2002085104A2 Methods of transforming plants
10/31/2002WO2002085094A2 Transgenic mice containing acylphosphatase gene disruptions
10/31/2002WO2002085093A2 Replikin peptides and uses thereof
10/31/2002WO2002070737A8 Compositions and methods relating to osteoarthritis
10/31/2002WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002WO2002068585A3 Tip39 polypeptides
10/31/2002WO2002066681A9 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
10/31/2002WO2002066658A3 Cloning vector comprising a system for direct selection of recombinants
10/31/2002WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002WO2002064814A3 Expression of human milk proteins in transgenic plants
10/31/2002WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002WO2002062949A3 Aptamer-mediated regulation of gene expression
10/31/2002WO2002062197A3 Markers for disease susceptibility and targets for therapy
10/31/2002WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002WO2002061048A3 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
10/31/2002WO2002060949A3 Glycoforms a fas ligand inhibitory protein analog
10/31/2002WO2002060477A9 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
10/31/2002WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002WO2002057433A9 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation
10/31/2002WO2002055713A3 58848, a human protein kinase family member and uses therefor
10/31/2002WO2002055548A8 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/31/2002WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002WO2002055535A3 Antisense modulation of cytohesin-1 expression
10/31/2002WO2002052022A3 Selective cytotoxic fusion proteins
10/31/2002WO2002046377A9 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants
10/31/2002WO2002046219A3 Rho-gtpase activating proteins and methods related thereto
10/31/2002WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002WO2002042455A3 Modifier of organelle metalbolism
10/31/2002WO2002040652A3 Novel soluble endoproteases for the in vitro processing of recombinant proteins
10/31/2002WO2002040544A3 Mutant human factor ix with an increased resistance to inhibition by heparin
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002033080A3 Regulation of human netrin binding membrane receptor unc5h-1
10/31/2002WO2002031137A3 Cytomegalovirus intron a fragments
10/31/2002WO2002029075A3 Multiple inducible gene regulation system
10/31/2002WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002WO2002024885A3 Regulation of human g protein-coupled receptor
10/31/2002WO2002020045A3 Vaccine against microbial pathogens
10/31/2002WO2002018560A3 Butinol i esterase
10/31/2002WO2002018419A3 Nucleotide sequences which code for the ccpa1 gene
10/31/2002WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/31/2002WO2002016563A3 14189, a human kinase and uses thereof
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002WO2002008434A3 Bicistronic influenza comprising two genes in tandem
10/31/2002WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002WO2002000250A3 Hiv-1 vaccines and screening methods therefor
10/31/2002WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002WO2001094635A3 Integrated active flux microfluidic devices and methods
10/31/2002WO2001078790A3 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE
10/31/2002WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002WO2001068812A9 Methods of stimulating cartilage formation
10/31/2002WO2001064898A3 Genes encoding denitrification enzymes
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001059081A9 Methods for using 20893, a human protein kinase
10/31/2002WO2001058953A9 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function
10/31/2002WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2
10/31/2002WO2001057251A9 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
10/31/2002WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002WO2001055369A9 Synthetic internal ribosome entry sites and methods of identifying same
10/31/2002WO2001055342A9 Synthetic genes for enhanced expression
10/31/2002WO2001054814A9 Compositions and methods for performing biological reactions
10/31/2002WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002WO2001051632A9 Odorant receptor polypeptides and nucleic acids encoding same
10/31/2002WO2001049844A9 Compositions and methods for gene silencing
10/31/2002WO2001047962A8 Attenuated microorganisms for the treatment of infection
10/31/2002US20020162142 Genes and methods for manipulation of growth
10/31/2002US20020162141 Selecting a target plant and transgene DNA molecule; constructing a plasmid; transforming an embryonic calli of target plant with tungsten particles coated with plasmid; culturing bombarded calli on a tissue culture medium
10/31/2002US20020162140 Expression of recombinant human acetylcholinesterase in transgenic plants
10/31/2002US20020162139 Maize metallothionein gene and promoter
10/31/2002US20020162138 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized
10/31/2002US20020162137 Materials and methods for the alteration of enzyme and acetyl coa levels in plants
10/31/2002US20020162136 For preventing and/or reducing fungal growth on a plant, plant tissue, seed or plant cell
10/31/2002US20020162135 To confer disease resistance to plant; transgenic plants are capable of fighting off phytopathogenic bacterial infection
10/31/2002US20020162134 Primordial germ cell-based germ line production of birds
10/31/2002US20020162133 Useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions
10/31/2002US20020162132 Useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions
10/31/2002US20020162130 Transgenic mouse expressing the human cyclooxygenase-2 gene and neuronal cell cultures derived therefrom
10/31/2002US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002US20020162128 Model animal for psychiatric disorders
10/31/2002US20020162126 Methods and compositions for RNA interference
10/31/2002US20020162125 Exposing to compound a mutant mouse, whose genome comprises a homozygous disruption of calcitonin gene related peptide (alpha CGRP) gene; determining response of mutant mouse to a nociceptive-inducing stimulus
10/31/2002US20020162124 Useful for studying phospholipid and cholesterol metabolism and for screening compounds designed to treat disorders of phospholipid and/or cholesterol metabolism
10/31/2002US20020161217 DNA encoding orphan SNORF40 receptor
10/31/2002US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002US20020161214 Novel human proteases and polynucleotides encoding the same
1 ... 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 ... 4023